NanoViricides Inc. (NNVC)

[bloomvest]

Im certain they'll talk about the great success they've been having with cides. NNVC expects to lead the market in the $40 billion herpes market; the great success of Ebolacide 2 and how it was developed in only 4 weeks; flucide 10,000x more effective then other drugs; oral flucide; secret discussions with companies; and of course buy more NNVC now when the stock is goin down; .... $100+++ billion potential in 2018.